Correlation Between Neurobo Pharmaceuticals and Cingulate
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Cingulate, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Cingulate.
Diversification Opportunities for Neurobo Pharmaceuticals and Cingulate
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurobo and Cingulate is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Cingulate go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Cingulate
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.17 times more return on investment than Cingulate. However, Neurobo Pharmaceuticals is 5.72 times less risky than Cingulate. It trades about 0.58 of its potential returns per unit of risk. Cingulate is currently generating about -0.11 per unit of risk. If you would invest 211.00 in Neurobo Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 3.00 from holding Neurobo Pharmaceuticals or generate 1.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 15.79% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Cingulate
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cingulate |
Neurobo Pharmaceuticals and Cingulate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Cingulate
The main advantage of trading using opposite Neurobo Pharmaceuticals and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |